title: Osteoblasts in bone physiology-mini review.
abstract: Bone structural integrity and shape are maintained by removal of old matrix by osteoclasts and in-situ synthesis of new bone by osteoblasts. These cells comprise the basic multicellular unit (BMU). Bone mass maintenance is determined by the net anabolic activity of the BMU, when the matrix elaboration of the osteoblasts equals or exceeds the bone resorption by the osteoclasts. The normal function of the BMU causes a continuous remodeling process of the bone, with deposition of bony matrix (osteoid) along the vectors of the generated force by gravity and attached muscle activity. The osteoblasts are derived from mesenchymal stem cells (MSCs). Circulating hormones and locally produced cytokines and growth factors modulate the replication and differentiation of osteoclast and osteoblast progenitors. The appropriate number of the osteoblasts in the BMU is determined by the differentiation of the precursor bone-marrow stem cells into mature osteoblasts, their proliferation with subsequent maturation into metabolically active osteocytes, and osteoblast degradation by apoptosis. Thus, the two crucial points to target when planning to control the osteoblast population are the processes of cell proliferation and apoptosis, which are regulated by cellular hedgehog and Wnt pathways that involve humoral and mechanical stimulations. Osteoblasts regulate both bone matrix synthesis and mineralization directly by their own synthetic activities, and bone resorption indirectly by its paracrinic effects on osteoclasts. The overall synthetic and regulatory activities of osteoblasts govern bone tissue integrity and shape.
authors.affiliation: Musculoskeletal Research Laboratory, Division of Orthopedics, Rambam Health Care Campus, and The Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
authors.forename: Nahum
authors.initials: N
authors.lastname: Rosenberg
authors.forename: Orit
authors.initials: O
authors.lastname: Rosenberg
authors.forename: Michael
authors.initials: M
authors.lastname: Soudry
keywords: Bone; Wnt; cytokines; hedgehog; mechanotransduction; osteoblast
references.citation: J Cell Biochem. 1994 Jul;55(3):273-86
references.pmid: 7962158
references.citation: J Bone Joint Surg Am. 2008 Feb;90 Suppl 1:19-24
references.pmid: 18292352
references.citation: Endocr Rev. 1993 Dec;14(6):690-709
references.pmid: 8119233
references.citation: J Bioenerg Biomembr. 2011 Dec;43(6):739-46
references.pmid: 22127435
references.citation: Bone. 2004 Sep;35(3):621-8
references.pmid: 15336597
references.citation: J Dent Res. 2010 Apr;89(4):331-43
references.pmid: 20200416
references.citation: J Bioenerg Biomembr. 1994 Oct;26(5):509-17
references.pmid: 7896766
references.citation: J Clin Invest. 1999 Aug;104(4):439-46
references.pmid: 10449436
references.citation: Endocrinology. 1997 Sep;138(9):3849-58
references.pmid: 9275074
references.citation: Biochem Biophys Res Commun. 2005 Mar 18;328(3):709-20
references.pmid: 15694405
references.citation: Rheum Dis Clin North Am. 1988 Dec;14(3):503-17
references.pmid: 3065838
references.citation: J Bone Miner Res. 1996 Feb;11(2):150-9
references.pmid: 8822338
references.citation: J Biol Chem. 2007 May 11;282(19):14515-24
references.pmid: 17351296
references.citation: J Bone Miner Res. 2001 Jun;16(6):975-84
references.pmid: 11393794
references.citation: Exp Cell Res. 2004 Jul 1;297(1):235-46
references.pmid: 15194439
references.citation: Mol Pathol. 1997 Jun;50(3):132-7
references.pmid: 9292147
references.citation: Nat Med. 2000 May;6(5):513-9
references.pmid: 10802706
references.citation: Ann Intern Med. 1996 Sep 1;125(5):413-5
references.pmid: 8702093
references.citation: Recent Prog Horm Res. 2002;57:385-409
references.pmid: 12017554
references.citation: Endocrinology. 2000 Dec;141(12):4768-76
references.pmid: 11108292
references.citation: J Bone Miner Res. 1998 May;13(5):793-802
references.pmid: 9610743
references.citation: J Clin Invest. 2002 Apr;109(8):1041-8
references.pmid: 11956241